[Posterior debridement, interbody fusion, internal fixation for treatment of lumbar discitis].
Zhongguo Gu Shang. 2017 Could 25;30(5):475-478
Authors: Chen L, Cheng J, Li B, Zhan FB, Zhang Y, Feng SL
Summary
OBJECTIVE: To guage the medical results of posterior debridement, interbody fusion with inside fixation within the therapy of lumbar discitis.
METHODS: The medical information of 13 sufferers with lumbar discitis handled from January 2005 to June 2012 was retrospectively analyzed. There have been 9 males and four females, aged from 31 to 68 years previous with a mean of 56 years previous. There have been 2 circumstances on L3, four, four circumstances on L4, 5, and seven circumstances on L5S1. Two circumstances sophisticated with diabetes, four circumstances with hypertension, and 1 case with out of date pulmonary tuberculosis. ESR stage of 13 circumstances was 12-89 mm/h with a mean of 42 mm/h; and C reactive protein fluctuations stage was stage Eight-114 ng/L with a mean of 47 ng/L. All of the sufferers denied historical past of operation or injection, and the primary symptom was extreme ache and limitation of movement in lumbar, with no efficacy for conservative strategies. Preoperative VAS was from 5 to 10 factors with a mean of seven.Eight factors. All sufferers have been handled with posterior debridement, interbody fusion, and inside fixation.
RESULTS: All of the sufferers left hospital after wound therapeutic, and the efficient antibiotics have been repeatedly used for four weeks intravenously and a pair of weeks for orally. All sufferers have been adopted up from 7 to 24 months with a mean of 18 months. VAS decreased for Zero-1 level. No inside fixation breakage, and recurrence have been discovered. Bone graft obtained fusion, and postoperative pathology confirmed phlogistic modifications.
CONCLUSIONS: One-stage posterior debridement, interbody fusion with inside fixation was an efficient technique in treating lumbar discitis, and it result in faster relived ache reduction and earlier mobilization.
PMID: 29417782 [PubMed – in process]